Palvella Therapeutics (PVLA) Tax Provisions (2014 - 2018)

Palvella Therapeutics (PVLA) has 4 years of Tax Provisions data on file, last reported at -$164000.0 in Q4 2018.

• On a quarterly basis, Tax Provisions fell 213.89% year-over-year to -$164000.0 in Q4 2018; TTM through Sep 2019 was -$164000.0, a 4000.0% decrease from a year earlier, with the FY2020 full-year figure at $164000.0, changed N/A from the prior year.
• Tax Provisions for Q4 2018 stood at -$164000.0, down from -$148000.0 in the prior quarter.
• Over the last five years, Tax Provisions for PVLA reached as high as $814000.0 in Q2 2017 and fell as low as -$164000.0 in Q4 2018.
• Historically, Tax Provisions has averaged $99581.2 across 4 years, with a median of $20211.5 in 2014.
• Across the five-year window, Tax Provisions jumped 224772.22% in 2015 and slumped 213.89% in 2018, its largest moves.
• Year by year, Tax Provisions stood at -$18.0 in 2014, then soared by 908016.67% to $163425.0 in 2015, then retreated by 11.89% to $144000.0 in 2017, then slumped by 213.89% to -$164000.0 in 2018.
• Per Business Quant data, the three most recent Tax Provisions figures were -$164000.0 in Q4 2018, -$148000.0 in Q2 2018, and $144000.0 in Q4 2017.